---
title: "Creative Medical Tech surges 111% in regular trading after USPTO approves Type 1 diabetes patent"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295128129.md"
description: "CELZ jumps 111% intraday as USPTO approves exosome-based immunotherapy patent for Type 1 diabetes."
datetime: "2026-08-06T16:28:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295128129.md)
  - [en](https://longbridge.com/en/news/295128129.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295128129.md)
generator: "portal-rs"
---

# Creative Medical Tech surges 111% in regular trading after USPTO approves Type 1 diabetes patent

Creative Medical Tech(CELZ.US) 盘中急涨，涨幅达**110.83%**，现报**1.41 美元**。

消息面上，公司近日获美国专利商标局（USPTO）批准一项基于外泌体的 1 型糖尿病免疫治疗专利申请。该专利涵盖干细胞编程的髓系细胞外泌体，旨在诱导免疫耐受并保护胰腺β细胞，进一步扩展了 MyeloCelz 平台的保护范围。此前公司已获得多项专利，保护期延伸至 2042 至 2043 年，产品组合包括 CELZ-201 和 CELZ-101。

### Related Stocks

- [CELZ.US](https://longbridge.com/en/quote/CELZ.US.md)

## Related News & Research

- [Creative Medical Technology Holdings stockholders approved increase in authorized common shares to 100 million](https://longbridge.com/en/news/297556623.md)
- [Creative Medical gets USPTO notice of allowance for exosome-based Type 1 diabetes immunotherapy patent application](https://longbridge.com/en/news/295116081.md)
- [Adobe enters a critical new chapter after 18 years](https://longbridge.com/en/news/298138912.md)
- [Affleck and Aflac. It was only a matter of time. | AFL Stock News](https://longbridge.com/en/news/298111704.md)
- [Creative Medical Technology Holdings issues mid-year update press release](https://longbridge.com/en/news/291420127.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**